BROADCASTS.com

b"Every week, The American Journal of Managed Care\\xae\\xa0(AJMC\\xae) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.\\n\\nThis week, the top managed care news included increased demand for long-acting contraception since President Trump took office; a payer decision on an insulin pump alarmed diabetes advocates; and despite being involved in cancer treatment decisions, many primary care providers don't feel prepared to do so.\\n\\nRead more about the stories in this podcast:\\nDemand for Long-Acting Contraception Increased in Wake of Concerns About Birth Control Access: https://www.ajmc.com/focus-of-the-week/demand-for-longacting-contraception-increased-in-wake-of-concerns-about-birth-control-access\\nJDRF Alarmed by Extension of UnitedHealthcare-Medtronic Pact to Youth With Type 1 Diabetes: https://www.ajmc.com/focus-of-the-week/jdrf-alarmed-by-extension-of-unitedhealthcaremedtronic-pact-to-youth-with-type1diabetes\\nDespite Being Involved in Cancer Treatment Decisions, PCPs Lack Knowledge, Confidence: https://www.ajmc.com/focus-of-the-week/despite-being-involved-in-cancer-treatment-decisions-pcps-lack-knowledge-confidence\\nExamining New Payment Ideas for Curative Therapies: https://www.ajmc.com/newsroom/examining-new-payment-ideas-for-curative-therapies\\nEvidence-Based Oncology - February 2019: https://www.ajmc.com/journals/evidence-based-oncology/2019/february-2019\\nRutgers' Janice Mehnert, MD, on Biomarkers, Being Inclusive in Clinical Trials, and Taking Time to Weigh the Options: https://www.ajmc.com/journals/evidence-based-oncology/2019/february-2019/rutgers-janice-mehnert-md-on-biomarkers-being-inclusive-in-clinical-trials-and-taking-time-to-weigh-the-options"